Seminars in Oncology
Volume 34, Supplement 5 , Pages S3-S7, December 2007

Clinical Management of T-Cell Malignancies: Current Perspectives, Key Issues, and Emerging Therapies

  • Bruce D. Cheson

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Bruce D. Cheson, MD, Georgetown University Hospital, 3800 Reservoir Rd NW, Washington, DC 20007
    • Dr Cheson has served as a member of the Advisory board for Seattle Genetics and Millennium Pharmaceuticals.

Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(07)00221-7

doi:10.1053/j.seminoncol.2007.11.001

Seminars in Oncology
Volume 34, Supplement 5 , Pages S3-S7, December 2007